CSPC Pharmaceutical's (HKG:1093) SYS6037 Injection obtained approval from the U.S. Food and Drug Administration (FDA) to conduct clinical trials in the U.S.

The mpox vaccine was co-developed by the company and the Institute of Microbiology, the Chinese Academy of Sciences, according to a Monday Hong Kong bourse filing.